About Clark Bosslet

As a member of ECG’s Children’s Hospitals practice, Clark works with academic medical centers and pediatric hospitals across the country to help them solve a broad range of financial and operational problems. He has extensive experience evaluating funds flow models, designing faculty compensation plans, and performing fair market valuations for physicians and physician groups. Recently, he worked on a yearlong engagement to integrate two major departments of pediatrics impacting over 500 faculty members and addressing issues related to clinical services, faculty employment and appointment models, residencies and fellowships, and research infrastructure. Previously, Clark worked on a pediatric department review at a major teaching hospital that involved the assessment of clinical and research efforts at the individual faculty and service line level, providing the client with a practical action plan for the future, as well as tools to help the department regularly benchmark its progress. He also helped to develop a regional pediatric strategy for two major pediatric providers in the Greater Seattle area. Prior to joining ECG, he worked as an internal Strategic and Financial Consultant at Texas Children’s Hospital in the finance department, where he performed market analyses and service line reviews, designed and executed patient flow analyses to assist with staffing projections, and led a team of more than 20 in the cross-functional implementation of a state grant valued at over $1 million. Clark earned a master of business administration degree in healthcare from Vanderbilt University and a bachelor of business administration degree from Texas A&M University.

Pediatric Post-Discharge Follow-Up: How to Get it Right

This post was written by Clark Bosslet, Manager, and Shelby Jergens, Senior Consultant.

In an earlier post, we talked about five key benefits pediatric units realize when they adopt the practice of making post-discharge follow-up calls to patient family members. In this post, we’ll look at call strategies, tactics, and even provide a sample script to guide hospital staff as they incorporate this follow-up model into their standard discharge process. Continue reading

A Call Worth Making: 5 Benefits of Pediatric Post-Discharge Follow-Up

This post was written by Clark Bosslet, Manager, and Shelby Jergens, Senior Consultant.

The moment of discharge following a long-term stay in a pediatric inpatient unit is emotional and chaotic. It is a huge relief for families to take their child home, but it can also be nerve-wracking to leave the safety of the hospital. The verbal instructions and bundle of paperwork received at discharge provide reassurance, but as families settle back in at home, their recollection of these important details can become hazy. Many hospitals have found that the best way to reengage families with their child’s care plan and increase patient adherence is to have familiar nurses or other advanced practice providers (APPs) from the unit follow up by phone within a few days of discharge. This practice has several key benefits: Continue reading

Pediatric-Research Affiliations – A Culture Clash With Upside

As the healthcare industry delves more deeply into a system driven by value-based care delivery, the effects of reform mandates are becoming more pronounced for children’s hospitals. Shrinking margins and financial pressures have led pediatric providers to revisit long-standing affiliation agreements and explore new modes of partnership.

A similar dynamic has unfolded with regard to research enterprises. Ongoing cuts to traditional sources of public funding are a growing concern for pediatric hospitals and their affiliated AMCs. NIH funding decreased 10% between 2010 and 2013,1  a drop felt most profoundly by smaller research centers. Public funding has recovered since that time but has yet to achieve its previous heights, leading some children’s hospitals to alleviate their financial constraints by pursuing partnerships with nontraditional sources – such as pharmaceutical and biotech companies. Continue reading